Fermented dairy products modulate Citrobacter rodentium-induced colonic hyperplasia

Journal of Infectious Diseases

Volumn 210, Issue 7, 2014, Pages 1029-1041

  Collins, James W ^a   Chervaux, Christian ^b   Raymond, Benoit ^a   Derrien, Muriel ^b   Brazeilles, Rémi ^c   Kosta, Artemis ^a,d   Chambaud, Isabelle ^b   Crepin, Valerie F ^a   Frankel, Gad ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Groupe Danone   (France)

^c C2R   (France)

^d CNRS and Aix Marseille University   (France)

Author keywords

Bioluminescence imaging; C. rodentium; DLIT CT; Fermented dairy products; Microbiota; Probiotic

Indexed keywords

DEXTRAN SULFATE;

ALCALIGENACEAE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIABILITY; CITROBACTER RODENTIUM; COLITIS; COLON DISEASE; COLONIC HYPERPLASIA; CONTROLLED STUDY; DAIRY PRODUCT; DISEASE MODEL; DISEASE PREDISPOSITION; FEMALE; FERMENTED PRODUCT; HOST PATHOGEN INTERACTION; HYPERPLASIA; INTESTINE CRYPT; INTESTINE FLORA; LACHNOSPIRACEAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RUMINOCOCCUS; SUPERNATANT; ANIMAL; BIOTA; C57BL MOUSE; COLON; DIET; ENTEROBACTERIACEAE INFECTIONS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PATHOLOGY; PROCEDURES;

ANIMALS; BIOTA; CITROBACTER RODENTIUM; COLON; DAIRY PRODUCTS; DIET; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HYPERPLASIA; MICE, INBRED C57BL;

EID: 84922391449     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu205     Document Type: Article

References (47)

1. Sanders ME, Guarner F, Guerrant R, et al. An update on the use and investigation of probiotics in health and disease. Gut 2013;62:787-96.
2. Huebner ES, Surawicz CM. Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol Clin North Am 2006;35:355-65.
3. Preidis GA, Hill C, Guerrant RL, Ramakrishna BS, Tannock GW, Versalovic J. Probiotics, enteric and diarrheal diseases, and global health. Gastroenterol 2011;140:8-14.
4. United Nations Food and Agriculture Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. http://www.who.int/foodsafety/publications/fsmanagement/en/probiotics.pdf. Accessed 16 June 2009.
5. Walter J. Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Appl Environ Microbiol 2008;74:4985-96.
6. Oozeer R, Leplingard A, Mater DD, et al. Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Appl Environ Microbiol 2006;72:5615-7.
7. Oozeer R, Goupil-Feuillerat N, Alpert CA, et al. Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice. Appl Environ Microbiol 2002;68:3570-4.
8. Rochet V, Rigottier-Gois L, Sutren M, et al. Effects of orally administered Lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans. Br J Nutr 2006;95:421-9.
9. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CG. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci USA 2007;104:7617-21.
10. Bernet-Camard MF, Lievin V, Brassart D, Neeser JR, Servin AL, Hudault S. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance (s) active in vitro and in vivo. Appl Environ Microbiol 1997;63:2747-53.
11. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterol 2001;121:580-91.
12. Chen X, Xu J, Shuai J, Chen J, Zhang Z, Fang W. The S-layer proteins of Lactobacillus crispatus strain ZJ001 is responsible for competitive exclusion against Escherichia coli O157:H7 and Salmonella typhimurium. Int J Food Microbiol 2007;115:307-12.
13. Fuller R. Probiotics: the scientific basis. London: Chapman & Hall, 1992.
14. Medellin-Pena MJ, Wang H, Johnson R, Anand S, Griffiths MW. Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Appl Environ Microbiol 2007;73:4259-67.
15. Gareau MG, Wine E, Reardon C, Sherman PM. Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. J Infect Dis 2010;201:81-91.
16. Chen CC, Chiu CH, Lin TY, Shi HN, Walker WA. Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells. Pediatr Res 2009;65:169-75.
17. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S. Citrobacter rodentium of mice and man. Cell Microbiol 2005;7:1697-706.
18. Wong AR, Pearson JS, Bright MD, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol 2011;80:1420-38.
19. Symonds EL, Riedel CU, O'Mahony D, Lapthorne S, O'Mahony L, Shanahan F. Involvement of T helper type 17 and regulatory T cell activity in Citrobacter rodentium invasion and inflammatory damage. Clin Exp Immunol 2009;157:148-54.
20. Collins JW, Akin AR, Kosta A, et al. Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentium-induced colonic inflammation and organ specificity of infection. Microbiology 2012;158:2826-34.
21. D'Arienzo R, Maurano F, Mazzarella G, et al. Bacillus subtilis spores reduce susceptibility to Citrobacter rodentium-mediated enteropathy in a mouse model. Res Microbiol 2006;157:891-7.
22. Fanning S, Hall LJ, Cronin M, et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci USA 2012;109:2108-13.
23. Johnson-Henry KC, Nadjafi M, Avitzur Y, et al. Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J Infect Dis 2005;191:2106-17.
24. Jones SE, Knight KL. Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella. Infect Immun 2012;80:710-9.
25. Rodrigues DM, Sousa AJ, Johnson-Henry KC, Sherman PM, Gareau MG. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J Infect Dis 2012;206:99-109.
26. Wu X, Vallance BA, Boyer L, et al. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol 2008;294:G295-306.
27. Wiles S, Clare S, Harker J, et al. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol 2004;6:963-72.
28. Collins JW, Meganck J, Kuo C, Francis KP, Frankel G. 4D Multimodality imaging of Citrobacter rodentium infections in mice. J Vis Exp 2013;78. doi:10.3791/50450.
29. Girard F, Dziva F, Van Diemen P, Phillips AD, Stevens MP, Frankel G. Adherence of enterohemorrhagic Escherichia coli O157, O26, and O111 strains to bovine intestinal explants ex vivo. Appl Environ Microbiol 2007;73:3084-90.
30. Matsuki T, Watanabe K, Fujimoto J, et al. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 2004;70:167-73.
31. Matsuda K, Tsuji H, Asahara T, Matsumoto K, Takada T, Nomoto K. Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 2009;75:1961-9.
32. Andersson AF, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand L. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008;3:e2836.
33. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6.
34. Li W, Godzik A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinfor 2006;22:1658-9.
35. Haas BJ, Gevers D, Earl AM, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Gen Res 2011;21:494-504.
36. Lê Cao K-A, Rossouw D, Robert-Granié C, Besse P. A sparse PLS for variable selection when integrating Omics data. Stat App Gen Mol Biol 2008;7. Article 35. doi:10.2202/1544-6115.1390.
37. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B 1995;57:289-300.
38. Chen CC, Louie S, Shi HN, Walker WA. Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr Res 2005;58:1185-91.
39. Vielfort K, Weyler L, Soderholm N, Engelbrecht M, Lofmark S, Aro H. Lactobacillus decelerates cervical epithelial cell cycle progression. PLoS One 2013;8:e63592.
40. Jones RM, Luo L, Ardita CS, et al. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J 2013;32:3017-28.
41. Van Baarlen P, Troost F, Van Der Meer C, et al. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci USA 2011;108(suppl 1):4562-9.
42. Yan F, Cao H, Cover TL, et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 2011;121:2242-53.
43. Hoffmann C, Hill DA, Minkah N, et al. Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Infect Immun 2009;77:4668-78.
44. Kamada N, Chen GY, Inohara N, Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013;14:685-90.
45. Djouzi Z, Andrieux C. Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with a human faecal flora. Br J Nutr 1997;78:313-24.
46. Zenewicz LA, Yin X, Wang G, et al. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J Immunol 2013;190:5306-12.
47. Kunisawa J, Kiyono H. Alcaligenes is commensal bacteria habituating in the gut-associated lymphoid tissue for the regulation of intestinal IgA responses. Front Immunol 2012;3:65.